CMS proposes rule change to Medicare Prescription Drug Program

CMS has issued proposed changes to the Medicare Prescription Drug Program and is asking for comments on the proposal by March 7.

The changes include strengthening fraud and abuse protections. They also include removing both antidepressant and immunosuppressant drugs from “protected” status in 2015. Protected status means that “all or substantially all” drugs within this class must be with the plan's formulary. CMS is also requesting information regarding the continued need to include antipsychotic drugs in a protected class through 2016. Antineoplastic, anticonvulsant and antiretroviral drugs will remain protected.

A summary of the proposed rule is available on the CMS website.